Brief: Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., To Support Ide Submission For Radiogel®
27/10/2025 13:40
Oct 27 (Reuters) - Vivos Inc RDGL.PK: VIVOS INC. RETAINS TOP FDA REGULATORY EXPERT DR. JOHN J. SMITH, M.D., J.D., TO SUPPORT IDE SUBMISSION FOR RADIOGEL® Source text: ID:nGNX4t8R4R Further company coverage: RDGL.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivos
See all newsBrief: Vivos Inc. Announces Progress Toward FDA Investigational Device Exemption (Ide) Submission
Brief: Vivos Inc. Strengthens Strategic Collaboration With Exubrion Therapeutics
Brief: Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., To Support Ide Submission For Radiogel®
Brief: Vivos Board Authorizes To Establish A Corporate Entity In India
Brief: Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025